Literature DB >> 9581847

Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.

K Kondo1, N Kohno, A Yokoyama, K Hiwada.   

Abstract

Two breast cancer cell lines, YMB-S and ZR-75-1S, were established in our laboratory. They proliferated in suspension culture without aggregation in a complete liquid medium. We found that sodium butyrate (NaB) arrested the cells in the G0-G1 phase of the cell cycle, inhibited their proliferation, and induced cell-cell and cell-surface adhesion. In this study, we explored the mechanism of this adhesion. Adhesion was inhibited by an anti-E-cadherin antibody, suggesting a role for E-cadherin. However, there were no changes in the expression of E-cadherin, alpha-catenin, and beta-catenin. Northern blot analysis and cytofluorometry revealed that NaB-treated cells showed a lower expression of MUC1 than did untreated cells. To examine the possibility that the adhesion of these cells might be induced by decreased MUC1 expression, the level of MUCI expression was directly reduced using an antisense oligonucleotide. The MUC1 antisense oligonucleotide induced cell-cell and cell-surface adhesion of these breast cancer cells, just as NaB did. Our observations indicate that E-cadherin can be functionally suppressed by overexpression of MUC1 but resumes its activity after suppression of MUC1 expression. Thus, regulation of MUC1 might be a new strategy for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581847

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Establishment and characterization of a rat pepsin-producing gastric cell line (OUMS-37)

Authors:  H Pu; C Gao; T Yuasa; M Namba; A Kondo; K Inada; M Sakaguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

Review 2.  Mucins and blastocyst attachment.

Authors:  Amantha Thathiah; Daniel D Carson
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

3.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

4.  O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.

Authors:  Pushpa Premaratne; Karin Welén; Jan-Erik Damber; Gunnar C Hansson; Malin Bäckström
Journal:  Tumour Biol       Date:  2010-09-26

5.  Endometrial receptivity defects and impaired implantation in diabetic NOD mice.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Biol Reprod       Date:  2012-08-02       Impact factor: 4.285

6.  MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.

Authors:  Kepal N Patel; Ellie Maghami; Volkert B Wreesmann; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Bhuvanesh Singh
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

Review 7.  Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors:  Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

8.  Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.

Authors:  Jing Yu; Rohit Bhargava; David J Dabbs
Journal:  Diagn Pathol       Date:  2010-06-15       Impact factor: 2.644

9.  Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.

Authors:  Qicheng Zhao; Monica Barclay; John Hilkens; Xiuli Guo; Hannah Barrow; Jonathan M Rhodes; Lu-Gang Yu
Journal:  Mol Cancer       Date:  2010-06-18       Impact factor: 27.401

10.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.